Charfty reglstratlon number 109094 Company reglstratlon numbor N1685604 (Northern Ireland) PULMONARY FIBROSIS NI ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 29 FEBRUARY 2024
PULMONARY FIBROSIS NI LEGALAND ADMINISTRATIVE INFORMATION Trustees T J Mcmillan J M Byrne M U M¢Millan P M Gorman I Simpson Dr. N Chaudhuri C J Donohoe (Appointed 26 June 2023} (Appointed 16 June 20231 Charity number 109094 Company numbor N1685604 Reglstered office 3 Chur¢hfield Road BallycastEe Northern Ireland BT54 6PJ Independent exan71ner MTS Prior Mcmahon 104-108 Fran$ Street Newtownards Down BT23 7DY
PULMONARY FIBROSIS NI CONTENTS Page Trustees, report Independent examineV$ Trport Statement of financial activities Balan stieet Notes to the financial statements 8-14
PULMONARY FIBROSIS NI TRUSTEES, REPORT (INCLUDING DIRECTORS. REPORT) FOR THE YEAR ENDED 29 FEBRUARY 2024 The trustees present their annual report and finaneAal statements for the year ended 29 February 2024. The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the financial sl8tements and comply with the ¢hariVs Igoverr¢ing do¢ument], the Companies Act 2006 and "Accounting and Reporting by Charities-. Statement of Recommended Practrce applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102}" (effective 1 January 2019). Constitution & Purpose Pulmonary Fibrosis Nl IPFNI} is a charity govemed by a COnstition & recognised as a Private Limited Company by guarantee without share capital use of 'Limited' by Companies House, incorporated 8 February 2022.. Company No. N1685604. Charity Number 109094. It is managed by the trustees. Trustees are appointed by inwtation & agreernent of the Trustee5 at the AGM or an Extraordinary General Meeting. Trustees may hold office for a maximum of 2 yeais before re-appointment is requiied unless they resign or are removed from office by a resolution of the other trustees at the AGM or an Extraordinary General Meeting. PFNI primarily seeks to benefit the Northern Ireland community through its activities which aim to provide support and relief for people living with Pulmonary Fibmsis and other Interstitial Lung Diseases in Northern Ireland and to advan education about Pulmonary Fibrosis and other Intersb'tial Lung Diseasés. Publlc Beneflt The public benefits that ffow from this purpose are lo- foster an abnosphere of mutual support and encouragement among people suffering from Pulmonary Fibrosis and other Interstitial Lung Diseases {PF} and their earer5. family and friends; raise awareness for the benefit of the public about the effects of Pulmonary Fibrosis and other Interstitial Lung Diseases and methods of management of such disease.. raise awareness for the benefit of the public about the effects of PulmorFary Fibrosis and other Interstrtial Lung Diseases and methods of management of such disease., a. promote and raise awareness of the Organ Donor Register for the benefit of the publi The beneficiaries of thi5 purpose are people living in Northern Ireland who have been diagnosed with pulmonary fibrosis and other interstitial lung diseases. their families. friends, colleagues. and the general public at large. The direct benefits flowing from this purpose include improved mentsl health and reduced levels of stress and anxiety eXperIend by our beneficiaries & an increase in their knowledge of how to live well with their condition. These benefits are emdenced through feedba¢k from beneficiaries at appropriate intervals. A private benefit owing from this purpose is the experieno and knowledge members receive. However, this is incidental and necessary as it is essential to ensure the benefit is promded to our beneficiar¢es. A private benefit is also gained by suppliers who receive payments for goods and servIS provided. The benefit is incidental and necessary lo ensure that benefit is provrded to our beneficiaries. Any expenses paid to TnJstee$ 15 reimbursement for expense5 necessarily incurred in pursuit of the aims of the charity or of purchases made on behalf of the charity.
PULMONARY FIBROSIS NI TRUSTEES. REPORT {INCLUDING DIRECTORS. REPORT) (CONTINUED) FOR THE YEAR ENDED 29 FEBRUAR Y 2024 The purposes of our charity may lead to the following risks.. a. Trips and falls when beneficiarFes are using: Puffin Lodge lour respite ¢aravan}. This facility is unsuitable for people who use wheelchairs or mobility scooters Dr who a unable to negotiate stairs. Site limitations are highlighted to applicants and mobility is assessed duang the application process. Events venues. Venues etc are assessed and chosen to ensure that the majority of our beneficiaries can attend & use safely and comft)rtably. b. Some beneficiaries require oxygen (021 which can be delivered to Puffin Lodge by BOC Ltd. The risks to beneficiaries associated with 02 include.. non-delivery by BOC {note- timely ordering of 02 for delivery to & use at Puffin Lodge is the responsibility of the beneficiary & they will contact BOC if this occurs).. The equipment required to meet the 02 requirements of the beneficiary would generate noise levels that are actsptable to other site users. Oxygen needs a discussed with the applicant and assessed during the application process. Unfortunately Puffin Lodge. due lo its location and construction, cannot facilitate the needs of all our beneficiaiies. 02 needs of beneficiaries are considered when organising events to ensure. as far as reasonably practicable. that the majority of benafictaries attend. The potential of any such harm or risk arising is ouelghed by the benefit provided to the public. The trustees have paid due regard to guidance issued by the Charity Commission in deciding what activtties the charity should undertake.
PULMONARY FIBROSIS NI TRUSTEES. REPORT (INCLUDING DIRECTORS. REPORT) (CONTINUED) FOR THE YEAR ENDED 29 FEBRUARY 2024 Revi9w of Publlc BenefitActivities In 2023124 PFNI continued to develop their activilies to reach and serve people with Pulmonary Fibrosi$ IPF), their carers and families. and increase awareness of PF wthin the community at large. Puffin Lodge, our respite static caravan in Ballycaslle was officially opened on 30 March 2023 by Robin Swann, MLA and ft)mier Health Minister and Pat Goman, ILD Specialist Nue at Antrim Area Hospital & 2022 Patients Choice Nurse of the Year. Throughout the year {Mar-Novl Puffin Lodge was well Ltsed by families to have a much needed break from home.- it also hosted fundraising coffee mornings which welcomed other Caravan owners and the general public and opened conversations aboLrt the work of PFNI. Further public benefit activities included= Production of a comprehensive infom)ation pack that clinicians give to their patients on diagnosis or ¢an be requested from PFNI directly. These were developed in co118boration with specialist PF dinicians. b. Weekty Zoom meeting were held for PF patients & monthly meeting for carers. Speakers from the Health Boards & Nl Hospi were invited to talk to attendees about issues relevant lo them including dealing with fatigue. nutrition. dealing with stress & anxiety. and the ever popular relaxation taster session. The number of Ambassadors increased during the year & an Ambassador Co-ordinator <T¥ustee) appointed. Ambassadors liaise with and assist beneficiarie5 in their local area d. Purchase of hand-held fan5 for distriblrtion to PF patients by clinicians. Education We attended numerous events where we were able to provide infom)ation to the public about Pulmonary Fibrosis and PFNI. These ranged from ftjndraising events lo specialist Conferen$. Our website is extensive and regulaity updated. We aim to support and supplement infomation prowded by clinicians about PF and ensure that all information provided is accurate and Current by liaising with medical professionals. Flnanclal revlew Annual Income During the year the Charity generated incoming resource5 of £279.528. All incomes were derived from personal or business donations and ftjndraising activities by our benefiaaries and supporteT$. Ann alE enditure Financially 2023124 was a satisfactory year for PFNI. Apart from costs associated with administration of the charity all expenditure was in the fvrtheran of the aims of the charity. All volLtnteers are entitted to receive oul-of-pocket expenses. All volunteers are entitled to re1ve travel expenses for joumeys on offiaal business which are paid at a standard rate accepted by HMRC as giving no personal gain to the recipient Outgoing reSOurS were £30,145 leaving net incoming resources of £249.383 for the year to 31 March 2023. Charity reserves should provide the organisation with adequate ffnancial stability and the means for it to meet ils charitable objectives for the foreseeable future. The Trustees retain fund5 in the Chartty to finance the ongoing running costs of the charity and to provide funds at short notice lo finan the objectives of Ihe charity.
PULMONARY FIBROSIS NI TRUSTEES, REPORT (INCLUDING DIRECTORS. REPORT) (CONTINUED) FOR THE YEAR ENDED 29 FEBRUARY 2024 Plans for future periods The Trustees of PFNI plan to= a. Purchase a propety that is suitable for use all-year-round by even more PF patients. their carers & families. that is disability friendly. and is located in an area thatls peaceful and relaxing for users. Encourage the use of both properties by those living with PF to enjoy so rest and relaxation. To continue lo build strong relationships with medical professionals. g. To continue to build re131ionships with local, national and international communities, businesses & char4tie5 to improve and increase awareness & knowledge of PF & PFNI. h. To provide events and activities to benefit the knowledge. mental health and wellbeing of our beneficiaries. To identify areas where we can provide support for family members of PF patients. including children. Structure, governance and management The trustees. who are also the directors for the purpose of company law. and who served during the year and up to the date of signature of the financial statements were- T J Mcmillan JMByme M U Mcmillan P M Gomian I Simpson Dr. N Chaudhuri C J Donohoe (Appointed 16 June 2023) (Appointed 16 June 2023) The trustee5' report was approved by the Board of Trustees. I lyl B .Jriic INOVJ Trustee 2024 13."44 GMI Tl 28 November 2024
PULMONARY FIBROSIS NI INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF PULMONARY FIBROSIS NI I report to the trustees on my examination of Ihe financial statements of Pulmonary Fibrosis Nl (the charity) for the year ended 29 February 2024. Responslbllltie$ and basis of report As the Irustees of the char¢ly (and also ils directors for the purposes of company law} you are responsible for the preparation of the financtal statements in accordan with the requirements of the Companies Act 2006 (the 2006 Acll. Havtng sab"sfied rnyself that the charity is not subject to audit under company law, and 1$ eligible for independent examination. it is my responsibility to.. examine the aixounts under section 65 of the Charities Act follow the procedures laid down in the general Diiections given by the Charity Commission for Northem Ireland under section 65(9){bl of the Charities Act State whether particular matters have come to my attention. Independent examinerfs statement Since the eharity's gross income exlxded £250.000 your examiner must be a member of a b¢Jdy listed in section 145 of the 2011 Act I confimi that l am qualified to undertake the examination because l am a member of Chartered Accountants Ireland. which is one of the listed bodies. I have examined your charity accounts as required under section 65 of the Charities Act and my examination was carried out in accordan with the general DirectTons given by the Charity Commission for Northern Ireland under section 6519)(b} of the Charities Act. The examinatiorE induded a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also included consideration of any unusual items or disclosuTes in the accounts. and seeking explanations from you as charity trustees concerning any such matters. I confimi that no matters have me to my attention in connection with the examination gimng me cause to believe that in any material respect.. accounting records were not kept in respect of the charity as reqltired by section 386 of the 2006 Act., or the financial statements do not accord with those records,- or the financial statements do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which 15 not a matter considered as part of an independent examination.. or the financi81 statements have not begn prepared in accordance wtlh the methods and principles of the Statement of Recommended Practi for accounting and reporting by charities applicable to charities preparing their accounts in ?ordanCe with the Financial Repoiting Standard applicable in the UK and Republic of Ireland IFRS 102). I have no cOnrS and have come across no other matters in connection with the examination to which attention should be dlawn in this report in order lo enable a proper understanding of the financial statements lo be reached. ko4 iuia Arinstronu INOV 28, 2024 17.'uO GlwlT) PaLFla Armstrong For and on behalf of MTS Prior Mcmahon hartered Accountants 104-108 Fran¢es Street Newtownards Down BT23 7DY Dated.. 28 November 2024
PULMONARY FIBROSIS NI STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT FOR THE YEAR ENDED 29 FEBRUAR Y 2024 Unrestricted funds 2024 Re$trl¢ted funds 2024 Total Unrestrlcted funds 2023 2024 Note$ Income from: Donations and legacies Other trading activities 67,802 82,466 129.260 197,062 82.466 46.403 49.520 Total Income 150,268 129.260 279,528 95.923 Expenditure on: Raising funds Charitable 8ctivilie5 2,500 27.645 2.500 27,645 235 20.827 Total expenditure 30.145 30.145 21.062 Net income and movement in funds 120.123 129,260 249.383 74,861 Reconclllation of funds: Fund balances at 1 March 2023 101,623 101,623 26.762 Fund balances at 29 February 2024 221,746 129.260 351.006 101.623 The statement of financial activities includes all gains and losses reeognised in the year. All incom& and expenditure derive from continuing activities.
PULMONARY FIBROSIS NI BALANCE SHEET ASAT29 FEBRUARY2024 2024 2023 Notes Flxod assets Tangible assets 12 57.247 62.630 Current assets Debtors Cash at bank and in hand 13 2,000 292.539 41,338 294,539 41,338 Creditors: amounts falling due wtthin one year 14 17801 {2,3451 Net current assets 293.759 38.993 Total assets less current liabilities 351.C106 101.623 Net assets excluding penslon liability 351.006 101.623 The funds of the charity Restricted income funds Unrestricted funds 15 129.260 221.746 101.623 351,(K)6 101,623 The company is enlilfed to the exemption from the audit requirement contained in section 477 of the Companies Act 2006. for the year ended 29 February 2024. The directors acknowledge their responsibilitie5 for complying with the requirements of the Companie5 Act 2006 with respect to accounting records and the preparation of financial slatemenls. The membets have not required the ¢ompany to obtain an audit of its financial statements for the year in que5ts.on In accordance with section 476. These financial statements have bèan prepared in accordance with tho promsions applicable to companies subject to the small companies regime. The financial statements were approved by the trustees on 28 November 2024 JudiLlI 1,-1 B yrite IN()v 3 JMByme Trustee 1024 13..44 GN.1Tj Company registrab'on number N1685604 (Northein Ireland)
PULMONARY FIBROSIS NI NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 29 FEBRUAR Y 2024 Accounting policies Charlty Infomiatlon Pulmonary Fibrosis Nl is a private company limited by guarantee incorporated in Northem Ireland. The registered office is 3 Churchfield Road. Ballycastle, BT54 6PJ. Northern Ireland. 1.1 Reporting perlod This is the first period of attount. 1.2 Accounting convention The financial statements have been prepared in accordan with the charity's Igoverning documentl. the Companies Act 2006. FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" I'FRS 102") and the Charities SORP "Accounting and Reporting by Charities.. Statement of Recommerided Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Iieland {FRS 1021" (effective l January 20191. The ¢harity is a Public Benefit Entity as defined by FRS 102. The charty has taken advantage of the provisions in the SORP for charities not to prepare a Statement of Cash Flows. The financial ststements are prepared in sterting, which is the fvnclional currency of the Charity. Monetsry amounts ill these financial statements are rounded lo e nearest £. The financial statements have been prepared under the historical cost convention. Imodified to indude the revaluation of freehold properbes and to include investment properties and certain financial instruments at fair valuel. The principal accounting policies adopted are set out below. 1.3 Going concem At the time of appmving the financial statements. the trustee5 have a reasonable expe¢talion th81 the charity has adequate resources to continue in operational existence for the foreseeable future. Thu5 the trustees continue to adopt the going concem basis of accounting in preparing the financial statements. 1A Charitable funds Unrestricted funds are available for vse at the discretion of the Irustees in furtherance of their tharitable objectives. Restricted fvnds are subject to $pe¢ifi¢ condibons by donors or grantors as to how they may be used. The purpose5 and uses of the restricted funds are Set out in the note$ 1¢ the financial statements. Endowment fvnds are subiect to specific conditions by donors that the capital must be maintained by the charity. 1.5 Income Income is recognised when the charity is legally entitled to Ét after any perfornian conditsons have been met. the amounts ¢an be measured reliably, and it is probable that incorne wll be received. Cash donations are recogni$ed on r¢¢eipt. Other donations are recognised once the charity has been notlfied of the donab'on, unless performance conditions require deferrel of the amount. Income tsx ie¢overable in relation to donaty'ons received under Gift Aid or deeds of covenant is recognised at the lime of the donation. Legacies are recognised on retsipt or otherwise if the charity has been notified of an impending distribution, the amount is known, and receipt Is expected. If the amount is not known, the tegacy is treated as a contingent asseL
PULMONARY FIBROSIS NI NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 29 FEBRUAR Y 2024 Accounting pollcles (Continued) 1.6 Expendlture Expenditure is recognised once there is a legal or constructive obligation to transfer e¢onomic benefit lo a third paty, it is probable that a transfer of economic benefits will be required in setttement, and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each actiwty. Direct costs attribLttable to a single activity are allocated directly lo that activity- Shared costs which contribute to more than one activ*ty and support costs which are not attributable to a single activÈly a apporboned beeen those activits.es on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreGtation char9es are allocated on the portion of the asset'5 use. 1.7 Tanglble fixed assets Tangible fixed assets are initially measured at cost and subsequently measured at cost or valualion. net of depreciation and any impairment losses. Depreciation is recognised $0 as to write off thè Cost or valuation of assets les$ their residual values over their usefvl lives on the following bases.. Puffin Lodge Fixtures and fittings Computers 10Yo Reducing balan 20¥0 Reducing balance 25% Straight line The gain or loss arising ori the disposal of an asset is determined as the difference belween the sale pioceeds ar2d the carying value of the asse( and is recognised in the statement of financial ackn-vibes. 1.8 ImpaiFment of tixed assets At each reporting end date. the charity reviews the carying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists. the recoverable amount of the asset is estimated in order to delemiine the extent of the impaiment loss (if any). 1.9 Cash and ea$h equivalents Cash and cash equivalents include eash in hand, deposits held at call with banks. other short-tem liquid investments with original matuiities of three months or less. 8nd bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities. 1.10 Financial instrument5 The tharity has elected to apply the provisions of Section 11 'Basic Financial lrtslruments, and Section 12 'Other Finanual Instruments Issues, of FRS 102 to all of its financial instnjments. Financial instruments are recognised in the ¢harity's balan sheet when the charity becomes paty lo the contractual provisions of the instrumenL Financial assets and liabilitie3 are offset, with the net amounts presented in the financial stalemenls. when there is a legally enforceable ruht to Sel off the recognised amounts and there is an intention to settle on a net basis or to realise the as5el and settle the liability simultaneously.
PULMONARY FIBROSIS NI NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 29 FEBRUARY 2024 Accounting policies (Continuod) Basle financlal assets Basic financial assets. whieh include debtors and cash and bank balances. are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitijtes a financing transaction, where the transaction is measured at Ihe present value of the luture receipts discounted at a market rale of interest. Financial assets dassified as receivable within one year are not amortised. Basie fiTnancial liabilities Basic financial liabilities. including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a finallcing transaction. where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabiltties dassified as payable within one yeaT are not amort15ed. Debt inslTument5 are Subsequently carried at amortised cost. using the effective intsrest rate method. Trade creditors are obligations to pay for goods or serv¢ces that have been acquired in the ordinary course of operattons from suppliers. Amounts payable are classified as current liabilits"e5 if payment is due within one year or les5. If not. they are presented as non-current liabilities. Trade creditors are recognised inib.ally at transaction price and subsequently measured at amortised cost using the effecb've interest method. Dereeognition of financlal Ilabllftles Financial liabilities are derecognised when the charity's contractual obligations expire or are dischaiged or cancelled. 1.11 Employee benofits The cost of any unused holiday entitlement is recognised in the period in which the employee's services are received. Termination benefits are recognised immediately as an expense when the charity is demonstrably committed to terminate the employment of an employee or to provide termination beneffts. Critical accounting estimates and Judgements In the application of the charity's accounb-ng policies. the trustees are required to make judgements. esb'mates and assumptions about the carying amount of assets and liabilities that are not readity apparent from other SoUrs. The estimates and associated assumptions are based on historic81 experien* and other factors that are consided to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions lo a¢¢ounting estimates are recognised in the pèriod in which the estimate is remsed where the revision affects only that period, or in the period of the revision and fijture period5 Whe the Tevision affects both ¢urrenl and futsjre periods. Income from donations and legacles Unrestricted Restrl¢ted funds funds 2024 2024 Total Unre9trfcted Reslri¢ted fund$ funds 2023 2023 Total 2024 2023 Donations and gifts 67,802 129,260 197,062 46,403 46.403 10-
PULMONARY FIBROSIS NI NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 29 FEBRUARY2024 Income from other trading actlvltles Unrestrlcted Unrestrlcted funds funds 2024 2023 Fundraising events 82,466 49,520 Expenditure on raising fund$ Unrestricted Unrestricted funds funds 2024 2023 Fundraising and publicity Support costs 2.500 235 Expènditure on charitable activities Heading
ac982
2024 Heading *ac982 2023 Dlre¢t costs Depreciation and impaimieTrt Insurance Puffin lodge costs Office expenses General expenses Postage Computer & website costs Telephone Printing Travel & Accommodation 7.341 897 7.195 3,711 529 5,274 654 2.569 184 2.742 177 2.687 707 191 918 90 2,608 2,200 Member Gifts & Services 3,885 26.032 18,527 Share of support and governance ¢o$ts l$eg note 7) Govemance 1.613 2,300 27,645 20.827 Analysls by fund Unreslricled funds 27,645 20,827 11
PULMONARY FIBROSIS NI NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 29 FEBRUARY2024 Support costs allocated to activities 2024 2023 Fundraising Goveman¢e costs 2,500 1,613 235 2.300 4,113 2.535 Analysod between: Fundraising Professional Fees 2,500 1.613 235 2.300 4.113 2.535 Net rnovement sn funds 2024 2023 The net movement in fvnds is slated after chargingl{crediting)'. Depreciation of owned tangible fixed assets 7,341 3.711 Trustees None of the trustees (or any persons connected with them) reiVed any remuneration or benefits from the charity during the year. 10 Employees The average monthly number ofemployees during the year was.. 2024 Number 2023 Number Total There wgre no employees whose annual remuneration was more than £60.000. Remunarotion of key management personnel The remuneration of key management personnel was as follows.. 11 Taxation The charity is exempl from taxation on its activities because all its income is applied for charitable purposes. 12-
PULMONARY FIBROSIS NI NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 29 FEBRUAR Y 2024 12 Tangible fixed assets Puffln Lodge Flxturas and fittings Computers Total Cost At 1 March 2023 Additions 61,199 3,873 1,269 1.958 66.341 1.958 At 29 Febfuary 2024 61,199 3,873 3.227 68,299 Depreciation and Impalmient At 1 March 2023 Depre¢iation charged in the year 3,060 5.814 387 863 264 664 3,711 7,341 At 29 February 2024 8,874 1.250 928 11.052 Carrying amount At 29 February 2024 52,325 2,623 2.299 57,247 At 28 February 2023 58.139 3.486 1.005 62,630 13 Debtors 2024 2023 Amounts falling due within one year- Prepayments and accrued income 2.000 14 Creditors- amounts falling due within one year 2024 2023 Other creditors Accruals and deferred income 45 2.3(10 780 780 2,345 15 Restricted funds The restricted funds of the Charlty Comprise the unexpended balan$ of donations and grants held on trust Subject to specific ¢onditions by donors as to how they may be used. At 1 March 2023 Incomlng At29 resources February 2024 129,260 129,260
PULMONARY FIBROSIS NI NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 29 FEBRUARY2024 16 Unrestrlcted funds The unrestricted fttnds of the charity comprise the unexpended balances of donations and grants which are not subject to specific conditions by donors and grantors as to how they may be used. These include designated funds which have been set aside out of unrestricted fund5 by the trustees for specific purposes. At l March 2023 Incoming resources Resources At29 expended February 2024 General funds 101,623 150.268 (30.145) 221,746 Previous period: At 1 Marth 2022 Incoming resources Resources At28 expended February 2023 General funds 26,762 95.923 {21.062) 101,623 17 Analysis of net assets between funds Unrestricted funds 2024 Restricted funds 2024 Total 2024 At 29 February 2024: Tangible assets Current assetsl{liabilities) 57,247 164.499 57,247 293.759 129.260 221,746 129.260 351.006 Unrestricted funds 2023 Restricted funds 2023 Total 2023 At 28 February 2023: Tangible assets Current assetsl{liabilitiesl 62,630 38.993 62,630 38,993 101,623 101,623 18 Related party transactlons There were no disclosable related party transactions during the year (2023 - none). 14-